NCT06005168View on ClinicalTrials.gov

Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

PHASE4RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Surgical Prophylaxis
Interventions
DRUG

Cefazolin for Injection

2 grams or 3 grams based on standard of care or morphomic-based decision

Trial Locations (1)

48108

RECRUITING

University of Michigan Hospital, Ann Arbor

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

University of Michigan

OTHER